Blood type method system and device

Details for Australian Patent Application No. 2005303388 (hide)

Owner Inverness Medical Switzerland GmbH

Inventors Fish, Falk; Samuels, Fred; Ben-Zvi, Ariela; Rott, Gennady

Agent Houlihan2

Pub. Number AU-A-2005303388

PCT Pub. Number WO2006/051548

Priority 60/627,162 15.11.04 US

Filing date 15 November 2005

Wipo publication date 18 May 2006

International Classifications

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

C12M 1/34 (2006.01) Apparatus for enzymology or microbiology - Measuring or testing with condition measuring or sensing means, e.g. colony counters

C12Q 1/56 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/051548 Priority application(s): WO2006/051548

23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303389-Combination therapy associating preferably a ceramide with a cytotoxic drug

2005303385-Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis